A Non-Interventional Pilot Study to Explore the Role of Gut Flora in Obesity

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

WITHDRAWN

Study Classification

OBSERVATIONAL

Study Start Date

2020-03-02

Study Completion Date

2030-07-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

This study seeks to correlate microbiome sequencing data with information provided by patients and their medical records regarding obesity.

Related Clinical Trials

Explore similar clinical trials based on study characteristics and research focus.

Fecal Microbiota Transplant for Improvement of Metabolism

NCT02530385

Obesity

COMPLETED PHASE1/PHASE2

Construction of an in Vitro Intestinal Microbial Ecological Simulation System for Obese People

NCT06621186

Obese Subjects

COMPLETED

Fecal Microbiota Transplant (FMT) to Induce Weight Loss in Obese Subjects

NCT03789461

Obesity

UNKNOWN NA

Fecal Microbiota Transplantation for the Treatment of Obesity

NCT02741518

Obesity

COMPLETED PHASE1/PHASE2

Fecal Microbial Transplantation and Fiber Supplementation in Participants With Obesity and Metabolic Syndrome.

NCT03477916

Obesity Metabolic Syndrome

COMPLETED PHASE2

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

The goal of this Research Study is to better understand how the genetic information in subject's microbiome correlates to the information provided in surveys and in medical records, particularly regarding obesity.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Overweight and Obesity Overweight or Obesity Obesity Obesity, Morbid Obesity, Abdominal Obesity; Familial Obesity; Endocrine Obesity, Visceral Obesity Hypoventilation Syndrome

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

CASE_ONLY

Study Time Perspective

PROSPECTIVE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Obsese individuals

Patients with a BMI greater than or equal to 30

No intervention

Intervention Type OTHER

There is no intervention for this study

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

No intervention

There is no intervention for this study

Intervention Type OTHER

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

1. Signed informed consent by patient
2. Male or female patients age 18 and older.
3. Diagnosis of obesity based on Body Mass Index (BMI) of 30 or greater.

Exclusion Criteria

1. Refusal by patient to sign informed consent form
2. Treatment with antibiotics within two weeks prior to screening
3. Treatment with probiotics within six weeks prior to screening
4. History of bariatric surgery, total colectomy with ileorectal anastomosis or proctocolectomy
5. Postoperative stoma, ostomy, or ileoanal pouch
6. Participation in any experimental drug protocol within the past 12 weeks
7. Treatment with total parenteral nutrition
8. Any clinically significant evidence of disease that could interfere with the subject's ability to enter the trial
9. Inability of patient to adequately communicate with the investigator or their respective designee and/or comply with the requirements of the entire study

Minimum Eligible Age

18 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No